Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Calistri

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cell Communication and Signaling : CCS|October 21, 2024
Spatial-transcriptomic profiling: a new lens for understanding myelofibrosis pathophysiologyEdoardo Peroni, Elisabetta Calistri, Rosario Amato, et al.
American Journal of Hematology|April 22, 2006
Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemiaElisabetta Calistri, Mario Tiribelli, Marta Battista, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cellsAngela Michelutti, Raffaella Stocchi, Anna Candoni, et al.
Haematologica|May 18, 2006
The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotypeDaniela Damiani, Mario Tiribelli, Elisabetta Calistri, et al.
Hematological Oncology|January 4, 2007
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotypeDaniela Damiani, Mario Tiribelli, Donatella Raspadori, et al.
Experimental Hematology|March 18, 2006
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recoveryFrancesca Patriarca, Cristina Skert, Alessandra Sperotto, et al.
Leukemia Research|September 3, 2013
EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemiaMario Tiribelli, Massimiliano Bonifacio, Elisabetta Calistri, et al.
International Journal of Biological Macromolecules|December 4, 2024
Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutationCamila Paz Quezada Meza, Valentina Salizzato, Elisabetta Calistri, et al.
Biomedicines|February 25, 2023
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation SequencingAlessandra Sperotto, Maria Teresa Bochicchio, Giorgia Simonetti, et al.
Hematological Oncology|July 21, 2012
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemiaRoberto Latagliata, Massimo Breccia, Carmen Fava, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cell Communication and Signaling : CCS|October 21, 2024
Spatial-transcriptomic profiling: a new lens for understanding myelofibrosis pathophysiologyEdoardo Peroni, Elisabetta Calistri, Rosario Amato, et al.
American Journal of Hematology|April 22, 2006
Epstein-Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemiaElisabetta Calistri, Mario Tiribelli, Marta Battista, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cellsAngela Michelutti, Raffaella Stocchi, Anna Candoni, et al.
Haematologica|May 18, 2006
The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotypeDaniela Damiani, Mario Tiribelli, Elisabetta Calistri, et al.
Hematological Oncology|January 4, 2007
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotypeDaniela Damiani, Mario Tiribelli, Donatella Raspadori, et al.
Experimental Hematology|March 18, 2006
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recoveryFrancesca Patriarca, Cristina Skert, Alessandra Sperotto, et al.
Leukemia Research|September 3, 2013
EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemiaMario Tiribelli, Massimiliano Bonifacio, Elisabetta Calistri, et al.
International Journal of Biological Macromolecules|December 4, 2024
Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutationCamila Paz Quezada Meza, Valentina Salizzato, Elisabetta Calistri, et al.
Biomedicines|February 25, 2023
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation SequencingAlessandra Sperotto, Maria Teresa Bochicchio, Giorgia Simonetti, et al.
Hematological Oncology|July 21, 2012
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemiaRoberto Latagliata, Massimo Breccia, Carmen Fava, et al.
Pageof 2